Editas Medicine Inc (EDIT)

Cost of Revenue

$20.26M

TTM · Period ending: · USD

EDIT logo

EDIT Cost of Revenue

Latest reported$20.26M
EDIT TTM Cost of Revenue ($5.07M → $20.26M)
High-resolution chart · PNG

EDIT cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Editas Medicine Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
20,258,000
36,439,000
62,549,000
111,160,000
92,984,000
78,223,000
53,039,000
5,894,000
5,809,000
34,168,000
70,563,000
121,095,000
160,907,000
174,787,000
174,959,000
160,514,000
148,453,000
138,547,000
142,508,000
166,459,000
171,110,000
165,364,000
157,997,000
131,282,000
120,068,000
115,626,000
96,898,000
94,827,000
89,568,000
98,721,000
104,179,000
97,885,000
100,838,000
85,438,000
83,159,000
83,570,000
74,006,000
67,118,000
56,979,000
35,970,000
28,988,000
25,840,000
18,846,000
15,415,000
12,819,000
6,249,000
5,073,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.